greeksoup/ stock research
Stock research / United States / RDY / Year to 31 March 2020

Dr. Reddy’s Laboratories Limited (RDY) annual results, year to 31 March 2020: revenue INR 174,600 million, from the 20-F

Dr. Reddy’s Laboratories Limited files a 20-F with the SEC once a year, in Indian rupees. In the year to 31 March 2020 it reported revenue of INR 174,600 million ($2.5 billion at the year's average rate), up 13.5% on the year before. Its profit attributable to shareholders was INR 19,498 million, up 3.7%, and diluted earnings per share INR 117.40.

Revenue
INR 174,600 million
+13.5% on the year
FY2016FY2020
Operating margin
9.2%
13.6% a year earlier
FY2016FY2020
Net income
INR 19,498 million
+3.7% on the year
FY2016FY2020
Diluted EPS
INR 117.40
+3.8% on the year
FY2016FY2020

this yearthe year beforeIn Indian rupees as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toMar 2019 †Mar 2020
Revenue153,851174,600
Cost of sales70,42180,591
Gross profit83,43094,009
Research and development15,60715,410
Selling, general and administrative48,68050,129
Operating profit20,88815,993
Finance costs1,163983
Profit before tax22,44318,032
Income tax3,648-1,466
Profit for the year18,79519,498
Profit attributable to shareholders18,79519,498
Filing20-F20-F
INR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toMar 2019 †Mar 2020
Diluted EPS113.09117.40
Basic EPS113.28117.63
Filing20-F20-F

INR per ordinary share, as filed.

Cash flow

Year toMar 2019 †Mar 2020
Cash from operations28,70429,841
Purchase of property, plant and equipment6,9554,846
Free cash flow21,74924,995
Cash from investing-7,727-4,923
Cash from financing-21,326-25,159
Depreciation and amortisation12,19012,472
Buybacks0.0474
Dividends paid4,0023,916
Filing20-F20-F

INR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toMar 2019 †Mar 2020
Funded by
Equity attributable to shareholders140,197154,988
Borrowings, as filed38,38122,011
Lease liabilities6091,787
Other liabilities46,24053,455
Total equity and liabilities225,427232,241
Owned
Property, plant and equipment54,08852,332
Goodwill3,9023,994
Other intangible assets44,36727,659
Cash and cash equivalents2,2282,053
Trade and other receivables39,86950,278
Inventories33,57935,066
Other assets47,39460,859
Total assets225,427232,241
Filing20-F20-F

INR million, at each fiscal year end.

Ratios on the filed lines

Year toMar 2019 †Mar 2020
Gross margin54.2%53.8%
Operating margin13.6%9.2%
Net margin12.2%11.2%
Free cash flow margin14.1%14.3%
Return on year-end equity13.4%12.6%
Effective tax rate16.3%-8.1%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 March 2020, filed 27 June 2022: the filing. The figures are in Indian rupees as filed.